• Low Risk of Severe COVID-19 in Children With Inflammatory Bowel Diseases

Low Risk of Severe COVID-19 in Children With Inflammatory Bowel Diseases

Pediatric patients with inflammatory bowel diseases (IBD) have a low risk of severe COVID-19, even when receiving biologic and/or other immune suppressive therapies, researchers report in Clinical Gastroenterology and Hepatology. These findings support recommendations to continue maintenance IBD treatment for pediatric patients throughout the currentpandemic. SARS-CoV2 enters human cells via

Read more

Use of Famotidine Associated With Improved Outcomes of Hospitalized COVID-19 Patients

In patients hospitalized with COVID-19 and not initially intubated, use of famotidine is associated with a 2-fold reduction in clinical deterioration leading to intubation or death, a retrospective study in Gastroenterology showed. Famotidine is a histamine-2 receptor antagonist that suppresses gastric acid production. In vitro, famotidine inhibits HIV replication, and a

Read more
  • What do Endoscopies Find in Patients With COVID-19?

What do Endoscopies Find in Patients With COVID-19?

Endoscopic examinations reveal abnormalities in a high proportion of COVID-19 cases, researchers report in Clinical Gastroenterology and Hepatology. Peptic ulcers and esophagitis were detected in most upper GI endoscopies, and colitis, ranging from mild to more severe ulcerative lesions, was the most common finding during colonoscopy. No endoscopists became infected

Read more
  • COVID-19: AGA Practice Updates and Research Article Collection

COVID-19: AGA Practice Updates and Research Article Collection

The American Gastroenterological Association (AGA) has created a special site to keep the gastroenterology and hepatology fields updated on clinical guidance, research findings, and physician resources for COVID-19. The COVID-19 Journal Collection provides links to all the articles on SARS-CoV-2 infection published in the AGA Journals. The latest news includes:

Read more
  • COVID-19 Detected in Gastrointestinal Tract and Feces

COVID-19 Detected in Gastrointestinal Tract and Feces

SARS-CoV-2  (COVID-19) and its receptor are present in the gastrointestinal tract, even after clearance of the virus from respiratory tract, researchers report in Gastroenterology. Infection with COVID-19 causes respiratory illnesses including severe respiratory syndrome (SARS), so it infects respiratory epithelial cells and spreads via respiratory tract. However, the viral target

Read more